EdgarLookup

Rein Therapeutics, Inc.

RNTX NASDAQ CIK: 0001420565 Pharmaceutical Preparations
View on SEC.gov →
Overview All Filings Annual Quarterly Insiders

Recent Filings

All 497 filings →
Form Description Date
10-K 10-K Mar 26, 2026
8-K 8-K Mar 2, 2026
8-K 8-K Feb 19, 2026
SCHEDULE 13G/A Feb 13, 2026
8-K 8-K Jan 16, 2026
8-K 8-K Dec 11, 2025
4 OWNERSHIP DOCUMENT Nov 18, 2025
10-Q 10-Q Nov 14, 2025
8-K 8-K Nov 3, 2025
4 OWNERSHIP DOCUMENT Oct 28, 2025

Insider Transactions

View all →
Insider Title Type Shares Owns After Date
Voss Value Master Fund, LP Purchase 104,183 @ $1.22 926,441 Nov 14, 2025
Voss Value-Oriented Special Situations Fund, LP Purchase 178,392 @ $1.39 500,000 Oct 24, 2025
WINDSOR JAMES BRIAN President and CEO Purchase 161 @ $2.25 161 Dec 5, 2024
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO Sale 1,900 @ $3.30 1,751,256 Jun 17, 2024
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO Sale 5,250 @ $3.25 1,763,000 Jun 12, 2024
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO Sale 3,184 @ $3.30 1,779,567 Jun 5, 2024
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO Sale 3,100 @ $4.10 1,807,357 May 1, 2024
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO Sale 274 @ $4.93 1,803,503 Apr 29, 2024
WINDSOR JAMES BRIAN President and COO Purchase 225 @ $3.37 225 Dec 15, 2023
WINDSOR JAMES BRIAN President and COO Purchase 5,076 @ $1.97 5,122 Nov 20, 2023